MammoSite RTS: The reporting of initial experiences and how to interpret

Annals of Surgical Oncology

Volumn 11, Issue 8, 2004, Pages 723-724

  Arthur, Douglas W ^a,c   Vicini, Frank A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DESQUAMATION; DOSIMETRY; EDITORIAL; ERYTHEMA; FOLLOW UP; HUMAN; MEDICAL INSTRUMENTATION; PATIENT COMPLIANCE; RADIATION INJURY; RADIATION THERAPY SYSTEM; SKIN INFECTION; SKIN TOXICITY; BALLOON DILATATION; BRACHYTHERAPY; BREAST TUMOR; FEMALE; METHODOLOGY; NOTE; RADIATION DOSE;

BALLOON DILATATION; BRACHYTHERAPY; BREAST NEOPLASMS; FEMALE; HUMANS; RADIOTHERAPY DOSAGE;

EID: 6944247965     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.06.924     Document Type: Editorial

References (5)

1. Consensus Statement: Treatment of Early-Stage Breast Cancer. NIH Consensus Development Conference, June 18-21, 1990. Vol. 8, No. 6. Bethesda, Maryland: National Institutes of Health, 1990: 1-9.
2. Arthur DW. Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer [editorial]. J Surg Oncol 2003;84:185-91.
3. Vicini FA, Kestin LL, Edmundson GK, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 1999;45:803-10.
4. Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004;8:739-46.
5. Astrahan MA, Jozsef G, Streeter OE Jr. Optimization of MammoSite therapy. Int J Radiat Oncol Biol Phys 2004;58: 220-32.